Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Syneron Medical's PicoWay picosecond laser approved by USFDA to treat pigmented lesions
Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented lesions.
- Read more about Piramal Imaging pleased to support study on assessing value of PET scans in Alzheimer’s disease and Dementia Diagnosis
Piramal Imaging is honoured to announce it will provide funding and support, along with other industry partners, for a major clinical study titled, "Imaging Dementia – Evidence for Amyloid Scanning" (IDEAS). The trial is designed to evaluate the impact of positron emission tomography (PET) scanning of beta-amyloid deposits in the diagnosis of Alzheimer’s disease (AD) and Dementia in a defined patient population.
- Read more about For heart disease research Chennai based Lifeline Hospital join hands with Russia
The Chennai based Frontier Lifeline Hospital (FLL) and The Institute for Atherosclerosis Research, Moscow in Russia, merge for a collaborative research agreement to study the ‘genetic similarities causing heart diseases in Russians & Indians’.
- Read more about Merck Collaborates with Maharashtra University to Build Diabetes and Hypertension Healthcare Capacity India
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.
23 April 2015

Lupin introduce Zaxine in Canada for liver disease treatment

Pharma Major Lupin’s Canadian subsidiary, Lupin Pharma Canada has launched its first Brand product Zaxine under a strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine in the Canada.
- Read more about AstraZeneca's selumetinib get US FDA orphan drug status for uveal melanoma treatment
AstraZeneca, a global, innovation-driven biopharmaceutical business, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the MEK inhibitor selumetinib, for the treatment of uveal melanoma.
- Read more about Health Ministry launched new system to take action related to non-availability and overcharging of medicines
All essential medicines specified in the National List of Essential Medicines, 2011 (NLEM) are included in the First Schedule of DPCO, 2013 and are under price control. However, Life saving drugs are not defined in the Drugs (Price Control) Order, 2013.

[adsense:336x280:8701650588]
- Read more about Siemens' Healthcare launch new ACUSON S2000 Helx ultrasound system for management of liver diseases
Liver disease is common problem. According to a study, one in 5 Indians is affected by liver disease. In Mumbai alone, nearly 2000 patients die annually from liver failure.
- Read more about Sandoz generic Copaxone get US FDA approval for to treat relapsing forms of multiple sclerosis
Sandoz, a global leader in generic pharmaceuticals and a subsidiary of Novartis, has received approval from the US Food and Drug Administration (FDA) for Glatopa. Glatopa is the first FDA-approved, substitutable generic version of Copaxone^®20mg, a treatment for relapsing forms of multiple sclerosis. Sandoz, together with Momenta, is proud to be the first company to receive FDA approval for a substitutable generic version of this important therapy.
- Read more about Bacteria use magnetic particles to create 'natural battery'
Bacteria can use tiny magnetic particles to effectively create a 'natural battery', a new study has found. The bacteria can load electrons onto and discharge electrons from microscopic particles of magnetite, researchers said. This discovery holds out the potential of using this mechanism to help clean up environmental pollution, and other bioengineering applications, they said.